|
(3) 5 of the 19 cases (26.3%) had peripheral T cell origin, including 4 cases of large cell type and 1 case of small cell type;
|
|
|
(3) 2 6 .3% (5 / 19)为外周T细胞性 ,大细胞性 4例 ,小细胞性 1例 ; |
|
(3) Amongthe most significantly down-regulated 30 genes, 8 have relationship with NF-кB signal transduction pathway and this implied that the change of NF-кB signal transduction pathway may related to the metastatic potential of cultured HCC cell strains.
|
|
|
(3)在MHCC97H细胞株中下调最显著的30个基因中，有8个基因和NF-κB细胞信号传导有关，提示NF-κB信号传导通路的异常改变与肝癌转移可能有关。 |
|
(3) Hyp was purified after cell collection, suspension, ammonium sulfate precipitation and Ni-NTA column chromatography.
|
|
|
3、离心发酵液以收集菌体,用缓冲液悬浮菌体,经过超声破碎、硫酸铵分级沉淀和Ni-NTA亲和层析,得到了电泳纯的Hyp。 |
|
(3) Universal DNA polymerase was used in PCR amplification instead of Pfu enzyme;
|
|
|
(3)在PCR反应中用普通的DNA聚合酶代替高保真酶(Pfu); |
|
(3)HI-RFP-S and RFP-S treatments improved the activity of SOD,POD and CAT,which impaired the hurt to cell membrane from O-·2.
|
|
|
(3)HI-RFP-S、RFP-S处理通过提高保护酶SOD、POD、CAT的活性抑制水稻‘R6’植株内的氧自由基水平,以减少氧自由基对细胞膜的损伤而提高水稻的抗盐性。 |
|
(3)Liver function:the bilirubin and transpeptidase have no difference(P>0.05),but albumin and total protein of therapy group were higher than control group(P<0.05).
|
|
|
(3)肝功能:两组胆红素、转氨酶治疗后无明显变化(P>0.05),但总蛋白、白蛋白均有提高,治疗组明显高于对照组,两组差异有显著性(P<0.05)。 |
|
(3)The expression of Bcl 2 in B cell lymphoma was significantly higher than that in T cell lymphoma.
|
|
|
（3）Bcl－2在B细胞性NHL中的表达高于T细胞性NHL。 |
|
(4) Analysis of chromosome and serum protein electrophoresis.
|
|
|
(4)染色体、血清蛋白电泳的分析等。 |
|
(4) Studies of detecting methods of chemical toxicity and toxicology;
|
|
|
(4)针对化学中毒的现场防控进行实验室检测与毒理学的研究。 |
|
(4) The expression of Bcl 2 in low grade B cell lymphoma was significantly higher than that in intermediate to high grade B cell lymphoma, while the expressive intensity of Fas L was the opposite.
|
|
|
（4）低度恶性B细胞性NHL中Bcl－2的表达高于中～高度恶性组，而Fas－L的表达强度低于中～高度恶性组。 |
|
(4)There were no significantly different with T cell lymphoma and B cell lymphoma of expressive rate and quantity of BNLF 1 gene.
|
|
|
(4 ) T、B细胞性淋巴瘤 BNL F- 1基因表达阳性率及含量无显著差异。 |
